| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -0.65% | -2.93% | +47.52% | +87.34% | 1,001B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 642B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 180B | |
| Average | -0.66% | -5.55% | +20.52% | +40.91% | 391.82B | |
| Weighted average by Cap. | -0.52% | -4.33% | +29.80% | +55.48% |
Employees
4
Sector
Pharmaceuticals
